Parkwalk Advisors
Parkwalk Advisors Ltd is a London-based venture capital firm established in 2009, specializing in investments in early and growth-stage technology companies, particularly those spun out from UK universities and research institutions. The firm focuses on sectors such as healthcare, energy, materials, artificial intelligence, big data, cleantech, medtech, and quantum computing. Parkwalk seeks to invest in companies with strong intellectual property and a clear path to market, typically committing between £250,000 and £10 million per investment. The firm is stage agnostic, engaging in various rounds of funding, including seed and Series C and beyond. It emphasizes investments in unquoted companies and aims to generate capital gains for its investors, benefiting from favorable tax relief programs in the UK. Parkwalk leverages extensive networks in academia and venture capital to access high-quality deal flow. In 2017, Parkwalk became a subsidiary of IP Group Plc, enhancing its capabilities in intellectual property commercialization.
Wayland Additive
Series A in 2024
Wayland Additive Limited is a West-Yorkshire based company pushing the boundaries of electron beam 3D printing. Wayland’s goal is to develop, manufacture and sell metal Additive Manufacturing (“AM” – 3D printing) machines to industrial end-users such as major players in the aerospace and medical industries.
Wayland Additive
Series B in 2023
Wayland Additive Limited is a West-Yorkshire based company pushing the boundaries of electron beam 3D printing. Wayland’s goal is to develop, manufacture and sell metal Additive Manufacturing (“AM” – 3D printing) machines to industrial end-users such as major players in the aerospace and medical industries.
OSSTEC specializes in advanced technology for orthopedic applications, focusing on the development of metal 3D printed bone healing implants. These innovative implants are designed to mimic the natural structure of bone, addressing the high failure rates associated with traditional orthopedic solutions. By stimulating long-term bone growth, OSSTEC's products aim to improve the quality of life for patients suffering from conditions such as osteoarthritis, enabling them to remain active and pain-free. The company's commitment to enhancing bone healing technology positions it as a key player in the orthopedic market.
Fuel3D is a developer of advanced 3D imaging technology that offers a handheld 3D scanning system capable of capturing high-resolution shape and color information. Initially created for the medical imaging sector at Oxford University, this point-and-shoot scanner is designed to facilitate the rapid generation of 3D images for diverse applications, including art, animation, and game development. The innovative technology combines pre-calibrated stereo cameras with photometric imaging, allowing users to quickly and affordably produce detailed 3D representations, which are typically expensive and time-consuming to create. Fuel3D aims to make high-quality 3D scanning accessible to a broader audience, including independent developers and artists. The company is led by CEO Stuart Mead, who has extensive experience in global technology ventures, and continues to adapt its technology for various markets beyond its original medical focus.
Wayland Additive
Series A in 2021
Wayland Additive Limited is a West-Yorkshire based company pushing the boundaries of electron beam 3D printing. Wayland’s goal is to develop, manufacture and sell metal Additive Manufacturing (“AM” – 3D printing) machines to industrial end-users such as major players in the aerospace and medical industries.
Fuel3D is a developer of advanced 3D imaging technology that offers a handheld 3D scanning system capable of capturing high-resolution shape and color information. Initially created for the medical imaging sector at Oxford University, this point-and-shoot scanner is designed to facilitate the rapid generation of 3D images for diverse applications, including art, animation, and game development. The innovative technology combines pre-calibrated stereo cameras with photometric imaging, allowing users to quickly and affordably produce detailed 3D representations, which are typically expensive and time-consuming to create. Fuel3D aims to make high-quality 3D scanning accessible to a broader audience, including independent developers and artists. The company is led by CEO Stuart Mead, who has extensive experience in global technology ventures, and continues to adapt its technology for various markets beyond its original medical focus.
Fuel3D
Venture Round in 2019
Fuel3D is a developer of advanced 3D imaging technology that offers a handheld 3D scanning system capable of capturing high-resolution shape and color information. Initially created for the medical imaging sector at Oxford University, this point-and-shoot scanner is designed to facilitate the rapid generation of 3D images for diverse applications, including art, animation, and game development. The innovative technology combines pre-calibrated stereo cameras with photometric imaging, allowing users to quickly and affordably produce detailed 3D representations, which are typically expensive and time-consuming to create. Fuel3D aims to make high-quality 3D scanning accessible to a broader audience, including independent developers and artists. The company is led by CEO Stuart Mead, who has extensive experience in global technology ventures, and continues to adapt its technology for various markets beyond its original medical focus.
OxSyBio's vision is to ultimately produce tissues that can be used by patients in the clinic for precision medicine and organ repair or replacement. At OxSyBio, they are developing 3D printing techniques to produce a range of tissue-like and functional tissues for medical research and clinical applications. Their technology is based on cutting-edge research conducted by Professor Hagan Bayley’s group in the Chemistry Department at the University of Oxford. A leader in the exploration of chemical and synthetic biology his expertise cover membrane protein structure and function, single molecule chemistry and 3D printing.
Fuel3D
Venture Round in 2017
Fuel3D is a developer of advanced 3D imaging technology that offers a handheld 3D scanning system capable of capturing high-resolution shape and color information. Initially created for the medical imaging sector at Oxford University, this point-and-shoot scanner is designed to facilitate the rapid generation of 3D images for diverse applications, including art, animation, and game development. The innovative technology combines pre-calibrated stereo cameras with photometric imaging, allowing users to quickly and affordably produce detailed 3D representations, which are typically expensive and time-consuming to create. Fuel3D aims to make high-quality 3D scanning accessible to a broader audience, including independent developers and artists. The company is led by CEO Stuart Mead, who has extensive experience in global technology ventures, and continues to adapt its technology for various markets beyond its original medical focus.
Tangentix
Series B in 2015
Tangentix, a UK-based Sheffield, UK-based startup that is exploring the use of 3D graphics compression.
Fuel3D is a developer of advanced 3D imaging technology that offers a handheld 3D scanning system capable of capturing high-resolution shape and color information. Initially created for the medical imaging sector at Oxford University, this point-and-shoot scanner is designed to facilitate the rapid generation of 3D images for diverse applications, including art, animation, and game development. The innovative technology combines pre-calibrated stereo cameras with photometric imaging, allowing users to quickly and affordably produce detailed 3D representations, which are typically expensive and time-consuming to create. Fuel3D aims to make high-quality 3D scanning accessible to a broader audience, including independent developers and artists. The company is led by CEO Stuart Mead, who has extensive experience in global technology ventures, and continues to adapt its technology for various markets beyond its original medical focus.
Fuel3D is a developer of advanced 3D imaging technology that offers a handheld 3D scanning system capable of capturing high-resolution shape and color information. Initially created for the medical imaging sector at Oxford University, this point-and-shoot scanner is designed to facilitate the rapid generation of 3D images for diverse applications, including art, animation, and game development. The innovative technology combines pre-calibrated stereo cameras with photometric imaging, allowing users to quickly and affordably produce detailed 3D representations, which are typically expensive and time-consuming to create. Fuel3D aims to make high-quality 3D scanning accessible to a broader audience, including independent developers and artists. The company is led by CEO Stuart Mead, who has extensive experience in global technology ventures, and continues to adapt its technology for various markets beyond its original medical focus.
Tangentix
Series A in 2013
Tangentix, a UK-based Sheffield, UK-based startup that is exploring the use of 3D graphics compression.
Reinnervate
Venture Round in 2013
ReInnervate Limited is a biotechnology company based in Durham, United Kingdom, founded in 2002. The company specializes in developing innovative technologies that support research in cell growth and function in vitro, particularly within the realm of stem cell biology. ReInnervate's offerings include 3D cell-culture products that allow scientists to create assays and models that closely replicate the in-vivo environment of cells. These technologies facilitate the controlled differentiation of stem cells and the formation of specific tissue types, thereby aiding in the development of diagnostics and treatments for neurodegenerative diseases.
Reinnervate
Series B in 2011
ReInnervate Limited is a biotechnology company based in Durham, United Kingdom, founded in 2002. The company specializes in developing innovative technologies that support research in cell growth and function in vitro, particularly within the realm of stem cell biology. ReInnervate's offerings include 3D cell-culture products that allow scientists to create assays and models that closely replicate the in-vivo environment of cells. These technologies facilitate the controlled differentiation of stem cells and the formation of specific tissue types, thereby aiding in the development of diagnostics and treatments for neurodegenerative diseases.
Eykona Medical
Series A in 2010
Eykona Medical develops and markets portable three dimensional imaging systems. Its systems are used to capture environments for videogames and in medical imaging for dermatological care. The company is based in Oxford, the United Kingdom.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at
support@teaserclub.com. Your feedback is most welcome.